Assay Development
Showing 1 - 25 of >10,000
Assay Development in Organ Transplant Recipients
Recruiting
- Organ Transplantation
- Transplantation Immunology
-
Atlanta, Georgia
- +1 more
Jun 22, 2022
Assay for Angelman Syndrome and Prader-Willi Syndrome
Not yet recruiting
- Angelman Syndrome
- Prader-Willi Syndrome
- Newborn Screening Assay
-
Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
Mar 30, 2023
Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)
Completed
- Ebola Virus Disease
- Marburg Virus Disease
- cAd3-Marburg
- cAd3-EBO-S
-
Oklahoma City, OklahomaOklahoma Blood Institute (OBI)
Aug 2, 2022
Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
Recruiting
- Leukemia, Myeloid, Acute
- Minimal Residual Disease
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital (NCCH)
Feb 2, 2023
Serum Endotoxin Assay to Predict Development of Postoperative
Not yet recruiting
- Nephrolithiasis
- Urosepsis
-
Miami, FloridaUniversity of Miami
Jul 8, 2022
Development ofNext Generation Sequencing -Based Assay to Detect
Completed
- Preeclampsia
-
Newark, Delaware
- +9 more
Apr 22, 2022
NGS-Based Assay of Blood Samples of Sepsis Rapid Bacterial
Recruiting
- Pneumonia
- +3 more
- NGS-based assay for bacterial identification
-
Chaïdári, Attiki, Greece
- +3 more
Nov 21, 2023
Risk Reduction Trial in Thika (PUMA)
Active, not recruiting
- Risk Reduction
- PUMA
-
Thika, Near Nairobi, KenyaKEMRI Partners in Health and Research Development (PHRD), Thika
Jan 11, 2023
rs243865 and Susceptibility to Cataract Development
Not yet recruiting
- Cataract
- genotyping assay by real-time PCR
- ELISA
-
Sohag, EgyptFaculty of Medicine Sohag University
Dec 31, 2022
Validate Volumetric Absorptive Microsampling (VAMS) Assay Trial in Cincinnati (Mitra Microsampler)
Completed
- Validate Volumetric Absorptive Microsampling (VAMS) Assay
- Mitra Microsampler
-
Cincinnati, OhioCincinnati Children's Hospital
Dec 19, 2022
Liquid Biopsy Collection Study
Completed
- Chaperonin-Containing TCP-1
- +3 more
-
Orlando, FloridaUniversity of Central Florida
Oct 4, 2023
Affected Pregnancies: Assay Development & Optimization in
Completed
- Down Syndrome
- Aneuploidy
- Maternal blood draw of 30 to 50ml
-
Phoenix, Arizona
- +9 more
Sep 16, 2021
From Non-Hematologic Cancer for Use in Development ofLiquid
Recruiting
- Non-hematologic Cancer
-
Riverside, CaliforniaCompassionate Care Research Group, Inc.
Sep 16, 2021
Development ofRapid and Accurate Diagnostic Assay for
Recruiting
- Tuberculosis
-
Seoul, Korea, Republic ofDepartment of Pulmonary and Critical Care Medicine and Clinical
Oct 26, 2021
Multi-dimensional Analysis of cfDNA
Recruiting
- Gastric Cancer
- whole genomic methylation and fragmentation profile analysis of cfDNA
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Air Force Military Medical Univ
Dec 25, 2022
Biomarkers for Invasive Mucormycosis
Not yet recruiting
- Mucorales Infection
- Mucormycosis
- Venous sample
- (no location specified)
May 31, 2022
Standardized Flow Cytometric Assay of Peripheral Blood
Active, not recruiting
- Myelodysplastic Syndromes
- Diagnostic Test: Flow cytometry analysis of neutrophil myeloperoxidase expression
-
Grenoble, FranceChu Grenoble Alpes
Oct 29, 2021
Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Recruiting
- Drug Resistant Tuberculosis
- +3 more
- Xpert® MTB/XDR
-
Gulele, Addis Ababa, Ethiopia
- +3 more
Jun 13, 2022
Syphilis Trial in United States (Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum, Aptima
Recruiting
- Syphilis
- Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum
- +2 more
-
Los Angeles, California
- +8 more
Oct 9, 2023
Development of a NIPTT for Detecting Copy Number Variations
Terminated
- Copy Number Variations
- MaterniT GENOME
-
New York, New YorkColumbia University
Feb 25, 2021
Pertussis Trial in Halifax (Adacel®)
Completed
- Pertussis
- Adacel®
-
Halifax, Nova Scotia, CanadaCanadian Center for Vaccinology
Sep 9, 2020
qPCR Cell Free DNA Assay asPotential Biomarker for Predicting
Active, not recruiting
- Metastatic Non-Small Cell Lung Carcinoma
- +2 more
- Blood-based cell-free cfDNA qPCR assay
-
Little Rock, Arkansas
- +11 more
Sep 27, 2021
Development of Automated Molecular Diagnostic Platform for
Enrolling by invitation
- Tuberculosis Infection
-
Seoul, Songpa, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jul 25, 2021
Tuberculosis Trial in Seoul (New technique vs Xpert)
Unknown status
- Tuberculosis
- New technique vs Xpert
-
Seoul, Songpa, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 28, 2021
Precision Medicine Platform for Novel Oral Anticoagulants
Recruiting
- Anticoagulant Adverse Reaction
- Pharmacogenomics
-
Kaohsiung, TaiwanKaohsiung Medical University Hospital
Aug 30, 2021